Juan Pablo Palavicini, PhD, an assistant professor in the Department of Cellular and Integrative Physiology; Jinjiao Wang, PhD, RN, the William and Berneice Castella Distinguished Professor in Aging Studies; and Yi Zhu, PhD, associate professor in the Department of Cellular and Integrative Physiology, received UT System Science and Technology Acquisition and Retention awards for their work in aging research.
Share This Story
On World Brain Day, UT Health San Antonio provides a preview of its new Center for Brain Health
Share This Story
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
Share This Story
In the past five years, UT Health San Antonio has conducted more than 600 clinical research projects with one goal in mind — making lives better for people in San Antonio, Texas and beyond through innovative solutions to today’s most challenging health problems.
Share This Story
Can stress lead to Alzheimer’s disease? It can in women who are post-menopausal, a study led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) shows. Analyzing data from 305 cognitively unimpaired participants in the Framingham Heart Study, a long-term and ongoing community-based cohort study of residents in […]
Share This Story
There might be such a thing as getting too much of a good night’s sleep. Sleeping nine hours or more per night is associated with worse cognitive performance, which is even more the case for those with depression, a study led by researchers at The University of Texas Health Science Center (UT Health San […]
Share This Story
In groundbreaking news for patients with movement disorders, neurologists with The University of Texas Health Science Center at San Antonio are among the nation’s first to use technology that enables deep brain stimulation that adapts as symptoms change.
Share This Story
Hispanics face nearly double the risk of developing Alzheimer’s disease compared to non-Hispanic whites, according to the National Institutes of Health National Institute on Aging.
Share This Story
Five years after the height of the SARS-CoV-2 (COVID-19) pandemic, scientists are beginning to unveil the infection’s potential long-term effects on the brain. We now know that following an acute COVID-19 infection, between 10% and 35% of people suffer from lingering effects called long COVID. For some people, these effects can be mild and short-lived, […]
Share This Story
Advancement in the detection and treatment of Alzheimer’s and other neurodegenerative diseases means more people can preserve brain health for longer. But a crisis looms as an onslaught of people at risk for neurodegenerative diseases in the next 40 years is met with a shortage of health care providers. According to the U.S. […]
Share This Story